- AU$430.09m
- AU$415.89m
- $8.05m
- 13
- 28
- 77
- 36
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.54 | ||
Price to Tang. Book | 1.64 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 35.08 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -19.6% | ||
Return on Equity | -21.26% | ||
Operating Margin | -621.75% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1.62 | 3.38 | 4.55 | 7.7 | 8.05 | 13.9 | 56.6 | 34.03% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
NOVONIX Limited is an Australia-based battery technology company. The Company provides advanced materials, equipment, and services for the global lithium-ion battery industry. The Company manufactures battery cell testing equipment in Canada and is growing its synthetic graphite anode material manufacturing operations in the United States. The Company operates through two divisions: NOVONIX Anode Materials division (NAM), and NOVONIX Battery Technology Solutions division (BTS). The NAM division manufactures synthetic graphite anode materials used to make lithium-ion batteries that power electric vehicles, personal electronics, medical devices, and energy storage units. The BTS division focuses on battery research and development, along with providing advanced battery testing equipment and services on a global scale. BTS provides front-line access across the battery value chain and delivers materials and technologies to support battery development.
Directors
- Anthony Bellas NEC
- John Burns CEO
- Rashda Buttar SVP
- Nick Liveris VBD
- Robert Natter EDR (73)
- Suzanne Yeates SEC
- Zhanna Golodryga DRC (65)
- Trevor Baker NED
- Robert Cooper NED
- Chris Hay NED
- Andrew Liveris NED (67)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 5th, 2012
- Public Since
- December 2nd, 2015
- No. of Shareholders
- 32,516
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 488,733,461
- Address
- Level 8, 46 Edward Street, BRISBANE, 4000
- Web
- https://www.novonixgroup.com/
- Phone
- Auditors
- PricewaterhouseCoopers
Upcoming Events for NVX
Novonix Ltd Annual Shareholders Meeting
NOVONIX Ltd Annual Shareholders Meeting
Full Year 2024 NOVONIX Ltd Earnings Release
Similar to NVX
1414 Degrees
Australian Stock Exchange - SEATS
Altech Batteries
Australian Stock Exchange - SEATS
Amaero International
Australian Stock Exchange - SEATS
AML3D
Australian Stock Exchange - SEATS
Austin Engineering
Australian Stock Exchange - SEATS
FAQ
As of Today at 18:15 UTC, shares in Novonix are trading at AU$0.88. This share price information is delayed by 15 minutes.
Shares in Novonix last closed at AU$0.88 and the price had moved by -22.81% over the past 365 days. In terms of relative price strength the Novonix share price has underperformed the ASX All Ordinaries Index by -31.4% over the past year.
The overall consensus recommendation for Novonix is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Novonix does not currently pay a dividend.
Novonix does not currently pay a dividend.
Novonix does not currently pay a dividend.
To buy shares in Novonix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.88, shares in Novonix had a market capitalisation of AU$430.09m.
Here are the trading details for Novonix:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: NVX
Based on an overall assessment of its quality, value and momentum Novonix is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Novonix is AU$1.10. That is 25% above the last closing price of AU$0.88.
Analysts covering Novonix currently have a consensus Earnings Per Share (EPS) forecast of -$0.14 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Novonix. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -6.33%.
As of the last closing price of AU$0.88, shares in Novonix were trading +7.86% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Novonix PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.88.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Novonix's management team is headed by:
- Anthony Bellas - NEC
- John Burns - CEO
- Rashda Buttar - SVP
- Nick Liveris - VBD
- Robert Natter - EDR
- Suzanne Yeates - SEC
- Zhanna Golodryga - DRC
- Trevor Baker - NED
- Robert Cooper - NED
- Chris Hay - NED
- Andrew Liveris - NED